 Multiple presentations reinforce clonoSEQs ability to provide valuable insights for treatment surveillance and clinical decision-making More than 30 clonoSEQ-related abstracts to be presented at the meeting SEATTLE, Dec. 10, 2022 GLOBE NEWSWIRE Adaptive Biotechnologies Corporation Nasdaq: ADPT, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ... The post Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Uti... 